VolitionRx Ltd
VNRX
18 hedge funds and large institutions have $13.4M invested in VolitionRx Ltd in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
9% more capital invested
Capital invested by funds: $12.3M → $13.4M (+$1.06M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.02% less ownership
Funds ownership: 0.88% → 0.86% (-0.02%)
5% less funds holding
Funds holding: 19 → 18 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$469K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$320K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$16.2K |
| 4 |
BBHC
Brown Brothers Harriman & Co
New York
|
+$11.2K |
| 5 |
Morgan Stanley
New York
|
+$5.85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Southpoint Capital Advisors
New York
|
-$698K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$322K |
| 3 |
Bank of New York Mellon
New York
|
-$58.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$5.03K |
VNRX Hedge Fund Activity: Q4 2017 in Review
18 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2017, worth a combined $13.4M — up 8.6% from $12.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VNRX and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was Lagoda Investment Management, adding an estimated $469K. The largest seller was Southpoint Capital Advisors, exiting entirely with an estimated $698K sold.
- 18 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2017, down from 19 in Q3 2017.
- Funds reported $13.4M of VolitionRx Ltd stock for Q4 2017, up 8.6% quarter-over-quarter.
- 2 funds opened new VolitionRx Ltd positions in Q4 2017 and 3 closed out, a net change of -1 holder.
- The largest VolitionRx Ltd buyer in Q4 2017 was Lagoda Investment Management, an estimated $469K added.
- The largest VolitionRx Ltd seller in Q4 2017 was Southpoint Capital Advisors, an estimated $698K sold.
Based on aggregated 13F filings for Q4 2017.